Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket trial for the treatment of various relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. The company's development pipeline includes vecabrutinib, a clinical-stage non-covalent ITK/BTK inhibitor and VRx-510 (formerly SNS-510), a preclinical-stage PDK-1 inhibitor. It is evaluating development and collaboration opportunities for vecabrutinib in combination with chimeric antigen receptor T-cell therapies and VRx-510 in various oncology indications. The company was formerly known as Sunesis Pharmaceuticals, Inc. to Viracta Therapeutics, Inc. in February 25, 2021. Viracta Therapeutics, Inc. was incorporated in 1998 and is headquartered in Cardiff-by-the-Sea, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Viracta Therapeutics Inc..
Viracta Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Viracta Therapeutics Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Viracta Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Viracta Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Viracta Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Viracta Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Viracta Therapeutics Inc.- Key Facts
2.2 Viracta Therapeutics Inc.- Geographic Locations
2.3 Viracta Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Viracta Therapeutics Inc.- Business Divisions
2.5 Viracta Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Viracta Therapeutics Inc. Strategic Analysis Review
3.1 Viracta Therapeutics Inc.- Key Strategies
3.2 Viracta Therapeutics Inc.- Company Outlook Statement
3.3 Viracta Therapeutics Inc.- SWOT Analysis
3.3.1 Viracta Therapeutics Inc.- Key Strengths
3.3.2 Viracta Therapeutics Inc.- Key Weaknesses
3.3.3 Viracta Therapeutics Inc.- Potential Opportunities
3.3.4 Viracta Therapeutics Inc.- Potential Threats
3.4 Viracta Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Viracta Therapeutics Inc.- Business Overview
4.2 Viracta Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Viracta Therapeutics Inc.- Key Products
5.2 Viracta Therapeutics Inc.- Key Service Areas
5.3 Viracta Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Viracta Therapeutics Inc.- Company History
6.2 Viracta Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Viracta Therapeutics Inc.- Income Statements
7.2 Viracta Therapeutics Inc.- Balance Sheet
7.3 Viracta Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Viracta Therapeutics Inc.- Direct Competitors
8.2 Viracta Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Viracta Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Viracta Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
